Cymbalta and Cannabis: What Is Known About the Risks of Combining Them
There is not enough clinical evidence to say that combining cannabis with Cymbalta is universally safe. Cymbalta—the brand name for duloxetine—does not have a well-established direct interaction with marijuana, but using the two together may increase unwanted effects and could alter how duloxetine is processed in the body.
Duloxetine is a serotonin and norepinephrine reuptake inhibitor (SNRI) approved for conditions including depression, generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. The medication is supplied as a delayed-release capsule; claims that Cymbalta comes in an immediate-release form are inaccurate.
Why the combination deserves caution
Both duloxetine and cannabis can cause dizziness, drowsiness, impaired concentration, changes in judgment, and problems with coordination. These effects may be more noticeable when the substances are used together. Anyone combining them should avoid driving, operating machinery, or taking other sedating substances until they know how the combination affects them.
The interaction may also depend on the cannabis product. THC and CBD can affect liver enzymes involved in drug metabolism, including CYP2D6 and CYP1A2. A pharmacology review concluded that these interactions are biologically plausible, but emphasized that the clinical importance—and the direction of the effect—remains uncertain. Smoking cannabis may affect drug metabolism differently from an edible, tincture, or concentrated CBD product.
There is also limited case-based evidence of possible serotonin toxicity involving cannabis and serotonergic antidepressants. One published case described a patient taking duloxetine who developed symptoms consistent with serotonin syndrome after using THC-infused food. A single case report cannot prove that cannabis and duloxetine caused the reaction, but it supports discussing cannabis use openly with the prescribing clinician.
Symptoms that need medical attention
Seek urgent medical care for agitation, confusion, hallucinations, fever, heavy sweating, a fast or irregular heartbeat, severe muscle stiffness or twitching, loss of coordination, seizures, or repeated vomiting or diarrhea. These symptoms can have several causes, including serotonin syndrome or a cannabis-related adverse reaction.
More common problems may include nausea, dry mouth, sleepiness, dizziness, sweating, constipation, appetite or weight changes, and sexual side effects. Cannabis can also worsen anxiety, panic, paranoia, or mood symptoms in some people, even when it helps others.
Do not stop Cymbalta suddenly
Stopping duloxetine abruptly can cause withdrawal symptoms such as dizziness, nausea, vomiting, diarrhea, sweating, irritability, anxiety, sleep problems, headache, and unusual sensations such as burning or tingling. Depression or anxiety may also return or worsen. Do not reduce the dose or replace Cymbalta with cannabis without first speaking with the prescriber.
What to discuss with a clinician
Before using cannabis while taking duloxetine, tell the prescriber or pharmacist which products you use, whether they contain THC, CBD, or both, how much you take, and whether you smoke, vape, or consume them. Also mention alcohol, sleep medicines, opioids, stimulants, antidepressants, migraine medicines, and supplements, since the overall combination may affect safety.
Duloxetine requires particular caution in people with liver disease, substantial alcohol use, severe kidney impairment, uncontrolled blood pressure, seizure disorders, glaucoma, or a history of bipolar disorder. Diabetes is not an automatic reason to avoid duloxetine, but blood sugar control may require monitoring. Pregnancy and breastfeeding should also be discussed individually with a healthcare professional rather than treated as blanket contraindications.
The safest conclusion is that cannabis and Cymbalta should not be combined casually. There is no reliable evidence establishing a universally safe dose or product combination, and research on cannabis-related drug interactions remains limited. A healthcare professional can help weigh the potential benefits and risks for the specific condition being treated and can suggest safer alternatives if adverse effects develop.
For general information about duloxetine’s approved uses, warnings, side effects, and withdrawal symptoms, consult the National Library of Medicine’s duloxetine medication guide. The FDA-approved Cymbalta prescribing information provides additional details for patients and clinicians.
